Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
Operating Margin for Kymera Therapeutics (KYMR)
Operating Margin as of May 2024 (TTM): -340.39%
According to Kymera Therapeutics's latest financial reports and stock price the company's current Operating Margin is -340.39%. At the end of 2021 the company had an Operating Margin of -137.60%.
Operating Margin history for Kymera Therapeutics from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -137.60% | 2.72% |
| 2020 | -133.96% | -90.47% |
| 2019 | -1,405.79% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.